Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
Hui‐Hui Cao, Jian‐Hong Chu, Hiu Yee Kwan, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 129

Showing 26-50 of 129 citing articles:

Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
Valeria Naponelli, Maria Teresa Rocchetti, Domenica Mangieri
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5569-5569
Open Access | Times Cited: 13
A Comprehensive Assessment of Apigenin as an Antiproliferative, Proapoptotic, Antiangiogenic and Immunomodulatory Phytocompound
Alexandra Ghițu, Anja Schwiebs, Heinfried H. Radeke, et al.
Nutrients (2019) Vol. 11, Iss. 4, pp. 858-858
Open Access | Times Cited: 76
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
Marisa Granato, Maria Saveria Gilardini Montani, Roberta Santarelli, et al.
Journal of Experimental & Clinical Cancer Research (2017) Vol. 36, Iss. 1
Open Access | Times Cited: 71
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
Cai M. Roberts, Michelle Tran, Mary Pitruzzello, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Progress in Research on the Role of Flavonoids in Lung Cancer
Oana Zănoagă, Cornelia Braicu, Ancuța Jurj, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4291-4291
Open Access | Times Cited: 68
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
Monica Marzagalli, Marina Montagnani Marelli, Lavinia Casati, et al.
Frontiers in Endocrinology (2016) Vol. 7
Open Access | Times Cited: 63
Apigenin as an effective anticancer natural product: Spotlight on TRAIL, WNT/β‐catenin, JAK‐STAT pathways, and microRNAs
Ülkü Özbey, Rükset Attar, Mirna Azalea Romero, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 2, pp. 1060-1067
Closed Access | Times Cited: 60
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway
Alexander Swoboda, Robert Soukup, Oliver Eckel, et al.
Oncogene (2020) Vol. 40, Iss. 6, pp. 1091-1105
Open Access | Times Cited: 55
The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives
Sayeh Mottaghi, Hassan Abbaszadeh
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6843-6861
Closed Access | Times Cited: 46
A comprehensive and current review on the role of flavonoids in lung cancer–Experimental and theoretical approaches
Şeyda Berk, Savaş Kaya, Esra Küpeli Akkol, et al.
Phytomedicine (2022) Vol. 98, pp. 153938-153938
Closed Access | Times Cited: 35
Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent
Yun Zhou, Yijun Yu, He Lv, et al.
Food and Chemical Toxicology (2022) Vol. 168, pp. 113385-113385
Closed Access | Times Cited: 32
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 1, pp. 3-18
Closed Access | Times Cited: 31
Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction
Laura Fossatelli, Zaira Maroccia, Carla Fiorentini, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 251-251
Open Access | Times Cited: 17
Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer
Yuzo Maeda, Hiroki Takahashi, Nozomu Nakai, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 56
Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion
Tinghong Ye, Shirui Zhu, Yongxia Zhu, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 82, pp. 319-326
Closed Access | Times Cited: 54
IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling
Cheng Chen, Xuejun Zhang
Journal of Translational Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Apigenin alleviates STZ-induced diabetic cardiomyopathy
Huang-Jun Liu, Yun-Lin Fan, Hai‐Han Liao, et al.
Molecular and Cellular Biochemistry (2017) Vol. 428, Iss. 1-2, pp. 9-21
Closed Access | Times Cited: 51
Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways
Reetobrata Basu, Shiyong Wu, John J. Kopchick
Oncotarget (2017) Vol. 8, Iss. 13, pp. 21579-21598
Open Access | Times Cited: 50
Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming
Edina Gyukity‐Sebestyen, Mária Harmati, Gabriella Dobra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 44
Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
Md. Abdul Aziz, Md Shahid Sarwar, Tahmina Akter, et al.
Life Sciences (2021) Vol. 268, pp. 118999-118999
Closed Access | Times Cited: 39
Apigenin Inhibits the Growth of Hepatocellular Carcinoma Cells by Affecting the Expression of microRNA Transcriptome
Shou‐Mei Wang, Peiwei Yang, Xiaojun Feng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 37
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 86-86
Open Access | Times Cited: 33
Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study
Tomohiro Nishina, Tomoko Fujita, Naoto Yoshizuka, et al.
BMJ Open (2022) Vol. 12, Iss. 10, pp. e055718-e055718
Open Access | Times Cited: 26
A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms
Siamak Daneshvar, Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 11, pp. 6789-6801
Open Access | Times Cited: 16
Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment
Ellen Schanknecht, Ava Bachari, Nazim Nassar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 859-859
Open Access | Times Cited: 14

Scroll to top